Insulet | PODD - Market Capitalization


Insulet reported $10.37B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 181.89B 10.88B Oct/2026
Align Technology USD 11.49B 585M Oct/2026
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 11.01B 2.34B Jun/2026
Becton, Dickinson and Co. USD 41.7B 3.07B Jun/2026
Boston Scientific USD 62.39B 872M Oct/2026
Cardinal Health USD 55.64B 5.92B Jun/2026
Cooper Companies USD 14.1B 1.83B Jun/2026
Dexcom USD 30.59B 4.6B Oct/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Globus Medical USD 10.73B 963M Jun/2026
ICU Medical USD 3.66B 434M Jun/2026
Insulet USD 10.55B 3.99B Jun/2026
Integra LifeSciences USD 926M 340M Oct/2026
J&J USD 607B 46.61B Oct/2026
Medtronic USD 109.3B 2.33B Jun/2026
Merit Medical Systems USD 5.44B 1.31B Oct/2026
Roche Holding CHF 270B 3.66B Jun/2026
Stryker USD 120.7B 5.15B Jun/2026
Tandem Diabetes Care USD 1.03B 276M Jun/2026
Teleflex USD 6.43B 815M Oct/2026
West Pharmaceutical Services USD 28.85B 3.48B Oct/2026
WK Kellogg Co USD 13.36B 2.04B Jun/2026
Zimmer Biomet Holdings USD 16.66B 845M Jun/2026